Antiplatelet Agents in Acute Coronary Syndrome: Interventions for Hospital and Community Pharmacists

Pharmacy Times, November 2015 Cough, Cold, & Flu, Volume 81, Issue 11

This Continuing Education activity is supported by an educational grant from Merck, Sharp and Dohme Corp.

This activity is supported by an educational grant from Merck, Sharp and Dohme Corp.

Antiplatelet Agents in Acute Coronary Syndrome: Interventions for Hospital and Community Pharmacists

Faculty

Nicholas B. Norgard, PharmD, BCPS

Clinical Assistant Professor

University at Buffalo, School of Pharmacy & Pharmaceutical Sciences

NYS Center of Excellence, Bioinformatics & Life Sciences

Buffalo, New York

Educational Objectives

After completing this continuing education program, the participant will be able to:

  • Explain practice guideline recommendations for antiplatelet agents in acute coronary syndrome (ACS).
  • Identify appropriate antiplatelet agents for individual patients.
  • Document interventions and pharmacist activities that improve quality of care and reduce readmissions in ACS.
  • Examine patient counseling techniques that reduce nonadherence in patients with ACS

Target audience:

Healthcare system,

ambulatory care, consultant, and

community pharmacists

Type of activity: Application

Release date: November 7, 2015

Expiration date: November 7, 2016

Estimated time to complete activity: 2.0 hours

Fee: Free

Pharmacy Times Office of Continuing Professional Education is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 2.0 contact hours (0.2 CEUs) under the ACPE universal activity number 0290-0000-15-144-H01-P. The activity is available for CE credit through November 7, 2016.